Tangible Shareholders Equity (Annual)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Harvard Bioscience, Inc. (HBIO) had Tangible Shareholders Equity of $-0.03M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$112.25M
Net Income	$-3.42M
Cost of Goods Sold	$46.18M
Gross Profit	$66.07M
Operating Expenses	$110.36M
Operating Income	$1.89M
Non-Operating Income/Expense	$-4.45M
Pre-Tax Income	$-2.56M
Normalized Pre-Tax Income	$-2.56M
Income after Taxes	$-3.42M
Income from Continuous Operations	$-3.42M
Consolidated Net Income/Loss	$-3.42M
Normalized Income after Taxes	$-3.42M
EBIT	$1.89M
EBITDA	$9.17M
Weighted-Average Shares Outstanding (Basic)	42.42M
Weighted-Average Shares Outstanding (Diluted)	42.42M
Earnings per Share (EPS) (Basic)	$-0.08
Earnings per Share (EPS) (Diluted)	$-0.08
Balance Sheet Financials
Current Assets	$49.04M
Property, Plant, and Equipment	$3.98M
Long-Term Assets	$88.33M
Total Assets	$137.37M
Current Liabilities	$26.54M
Long-Term Debt	$30.70M
Long-Term Liabilities	$37.75M
Total Liabilities	$64.29M
Common Equity	$73.07M
Tangible Shareholders Equity	$-0.03M
Shareholders Equity	$73.07M
Common Shares Outstanding	43.40M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$14.03M
Cash Flow from Investing Activities	$-1.80M
Cash Flow from Financial Activities	$-12.13M
Beginning Cash	$4.51M
End Cash	$4.28M
Increase/Decrease in Cash	$-0.23M
Stock-Based Compensation	$5.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.50
Gross Margin	58.86%
Operating Margin	1.69%
EBIT Margin	1.69%
EBITDA Margin	8.17%
Pre-Tax Profit Margin	-2.28%
Profit Margin	-3.04%
Free Cash Flow	$12.75M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.82
Inventory Turnover	1.87
Receiveable Turnover	6.97
Days Sales in Receivables	52.35
Return on Equity	-4.67%
Return on Tangible Equity	12647.95%
Return on Assets	-2.49%
Return on Investments	-3.29%
Book Value Per Share	$1.68
Free Cash Flow per Share	$0.30
Operating Cash Flow per Share	$0.33

Data from Zacks Investment Research, Inc.